These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10687027)
1. [Antimicrobial agents in the future. The contribution of genomics to their design]. Egorov AM; Sazykin IuO Antibiot Khimioter; 1999; 44(12):5-14. PubMed ID: 10687027 [No Abstract] [Full Text] [Related]
2. Virulence as a target for antimicrobial chemotherapy. Alksne LE Expert Opin Investig Drugs; 2002 Aug; 11(8):1149-59. PubMed ID: 12150708 [TBL] [Abstract][Full Text] [Related]
3. [Role of drug efflux pumps in bacterial multidrug resistance and virulence. Analysis to identify novel drug targets and counteract multidrug resistance and virulence]. Nishino K Jpn J Antibiot; 2008 Apr; 61(2):105-13. PubMed ID: 18669419 [No Abstract] [Full Text] [Related]
4. [Genome analysis of pathogenic microorganism--present and future]. Hayashi H Nihon Rinsho; 2003 Mar; 61 Suppl 3():405-13. PubMed ID: 12718003 [No Abstract] [Full Text] [Related]
5. Genomics and antimicrobial drug discovery. Moir DT; Shaw KJ; Hare RS; Vovis GF Antimicrob Agents Chemother; 1999 Mar; 43(3):439-46. PubMed ID: 10049248 [No Abstract] [Full Text] [Related]
6. [Biology of the pathogenic bacterial genome: impact of survival strategy in pathogenic bacteria]. Ohta T Seikagaku; 2007 Nov; 79(11):1032-45. PubMed ID: 18095457 [No Abstract] [Full Text] [Related]
7. [Bacterial genome analysis and its implications on the researches of pathogenic bacteria]. Hayashi T Nihon Rinsho; 2003 Mar; 61 Suppl 3():414-22. PubMed ID: 12718004 [No Abstract] [Full Text] [Related]
8. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time? Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283 [TBL] [Abstract][Full Text] [Related]
9. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. Chopra I; Hodgson J; Metcalf B; Poste G JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021 [No Abstract] [Full Text] [Related]
14. Bacterial targets and antibiotics: genome-based drug discovery. Gray CP; Keck W Cell Mol Life Sci; 1999 Nov; 56(9-10):779-87. PubMed ID: 11212338 [TBL] [Abstract][Full Text] [Related]
15. Use of genomics to select antibacterial targets. Pucci MJ Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986 [TBL] [Abstract][Full Text] [Related]
16. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs]. Gintsburg AL; Zigangirova NA; Zorina VV Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396 [TBL] [Abstract][Full Text] [Related]
17. Searching for drug targets in microbial genomes. Galperin MY; Koonin EV Curr Opin Biotechnol; 1999 Dec; 10(6):571-8. PubMed ID: 10600691 [TBL] [Abstract][Full Text] [Related]
18. Genome-enabled perspectives on the composition, evolution, and expression of virulence determinants in bacterial plant pathogens. Lindeberg M Annu Rev Phytopathol; 2012; 50():111-32. PubMed ID: 22559066 [TBL] [Abstract][Full Text] [Related]